Current stage-Stage I - Page 3 of 20 Posts on Medivizor
Navigation Menu

Current stage-Stage I Posts on Medivizor

Investigating the effectiveness of the treatment combination atezolizumab with chemotherapy before surgery for early triple negative breast cancer

Investigating the effectiveness of the treatment combination atezolizumab with chemotherapy before surgery for early triple negative breast cancer

Posted by on Oct 11, 2020 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of atezolizumab (Tecentriq) as an addition to chemotherapy before surgery for patients with early-stage triple-negative breast cancer (TNBC). The data showed that the combination is effective in improving treatment response in these patients. Some background...

Read More

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Posted by on Oct 4, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the survival rates for older patients with early-stage breast cancer (BC) receiving hormone therapy (HT), radiation (RT), both or none after breast-conserving surgery (BCS). The data showed that RT and HT in combination and RT alone may lead to higher survival expectancy than HT alone. Some...

Read More

An examination of pertuzumab and trastuzumab as breast cancer treatment before surgery in a real-life setting

An examination of pertuzumab and trastuzumab as breast cancer treatment before surgery in a real-life setting

Posted by on Sep 26, 2020 in Breast cancer | 0 comments

In a nutshell This study examined the effectiveness and safety of the drug combination pertuzumab (Perjeta) and trastuzumab (Herceptin) as a treatment for breast cancer (BC) with positive HER2 (human epidermal growth factor receptor 2) before surgery to remove the tumor in a real-world setting. The data showed that this...

Read More

The effects of cholesterol-lowering drugs on breast cancer relapse in postmenopausal women under aromatase inhibitor treatment

The effects of cholesterol-lowering drugs on breast cancer relapse in postmenopausal women under aromatase inhibitor treatment

Posted by on Jul 5, 2020 in Breast cancer | 0 comments

In a nutshell The study evaluated the link between statin (cholesterol-lowering drugs) use and risks of breast cancer (BC) relapse under adjuvant aromatase inhibitors (AI) therapy in women after their menopause. The main finding was that statin use was related with lower risks of BC relapse in such patients. Some background Women with...

Read More

Does chemotherapy and SBRT improve survival in older patients with early stage non-small cell lung cancer (NSCLC)?

Does chemotherapy and SBRT improve survival in older patients with early stage non-small cell lung cancer (NSCLC)?

Posted by on Jun 7, 2020 in Lung cancer | 0 comments

In a nutshell This study investigated chemotherapy (CT) and stereotactic body radiotherapy (SBRT) in older patients with early-stage non-small cell lung cancer (NSCLC). They found that CT after SBRT improved survival in older patients with tumors greater than 4 cm. Some background Non-small cell lung cancer (NSCLC) is the most common form of lung...

Read More

How effective is hormonal therapy for patients with hormone receptor positive early breast cancer?

Posted by on Apr 25, 2020 in Breast cancer | 0 comments

In a nutshell This study examined the effectiveness of hormonal therapy in premenopausal women with hormone receptor-positive early breast cancer with or without other treatments. The authors concluded that patients who received hormonal therapy had a higher chance of survival and without a return of cancer. Some background The hormone...

Read More

Benefits of therapy for early stage breast cancer

Posted by on Feb 29, 2020 in Breast cancer | 0 comments

In a nutshell This paper is a document that was developed at a breast cancer conference by a number of experts in the field. It outlines suggested treatment for early-stage breast cancer. The experts concluded that patients and doctors should work together and discuss the benefit of treating early-stage breast cancer in comparison with the potential...

Read More

Are intense follow-up programs beneficial for patients with colorectal cancer?

Posted by on Jan 10, 2020 in Colorectal cancer | 0 comments

In a nutshell This study reviewed the effect of follow-up programs on the survival of patients with colorectal cancer. Researchers suggested that intense follow-up programs do not improve the survival of these patients. Some background Colorectal cancer is a commonly diagnosed cancer in the US. Two in three patients will present with the possibly...

Read More

Complete mesocolic excision reduces the risk of recurrence in patients with colon cancer

Posted by on Dec 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of complete mesocolic excision (CME) in patients with right-side colon cancer. Researchers suggested that CME reduces the risk of recurrences (when cancer comes back) in these patients. Some background Colorectal cancer is one of the most common cancers worldwide. The standard treatment is surgery and...

Read More